Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience.

作者: Daniel I. Hoffman , Paul J. Zhang , Julia Tchou

DOI: 10.1016/J.SURONC.2019.01.009

关键词:

摘要: Abstract Background Non-classic lobular carcinoma in situ (NC-LCIS) is a rare pre-cancer breast lesion that warrants excision to exclude invasive disease. In patients pursuing breast-conserving surgery (BCS) for NC-LCIS, the need wide surgical margins controversial. We characterized outcomes of women diagnosed with NC-LCIS at large, academic medical center. Methods Female seen our institution from 2008 2018 pure were retrospectively identified. Patients excluded if was background cancer or ductal situ. Clinicopathologic and follow-up data collected. Rates upstage, re-excision, recurrence calculated. Results identified 26 on biopsy. 80.8% initially pursued conservation, while 19.2% underwent mastectomy. At definitive surgery, 11.5% upstaged. Among 19 non-upstaged BCS, 47.4% had least one re-excision 26.3% converted receiving BCS without completion mastectomy, 64.3% final negative 35.7% positive close margins. No recurrences observed. One patient developed 8.3 years post-surgery, did 2.2 post-surgery. All alive time analysis no evidence Conclusion presented largest series NC-LCIS. re-excisions mastectomies common. However, when achieved, prognosis excellent.

参考文章(17)
Carol Schiller, Seema A Khan, Megan E Sullivan, Barbara Susnik, Yurdanur Sullu, Yurdanur Sullu, Lobular Carcinoma In Situ Variants in Breast Cores: Potential for Misdiagnosis, Upgrade Rates at Surgical Excision, and Practical Implications Archives of Pathology & Laboratory Medicine. ,vol. 134, pp. 1024- 1028 ,(2010) , 10.1043/2009-0300-OA.1
Andrew Pieri, Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice? World journal of clinical oncology. ,vol. 5, pp. 546- 553 ,(2014) , 10.5306/WJCO.V5.I3.546
Christopher I. Li, Kathleen E. Malone, Babette S. Saltzman, Janet R. Daling, Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer. ,vol. 106, pp. 2104- 2112 ,(2006) , 10.1002/CNCR.21864
Thaer Khoury, Rouzan G Karabakhtsian, David Mattson, Li Yan, Susanna Syriac, Fadi Habib, Song Liu, Mohamed M Desouki, Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases Histopathology. ,vol. 64, pp. 981- 993 ,(2014) , 10.1111/HIS.12353
Sarah L. Blair, Derek K. Emerson, Swati Kulkarni, E. Shelley Hwang, Vanessa Malcarne, David W. Ollila, Breast surgeon's survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ. Breast Journal. ,vol. 19, pp. 116- 118 ,(2013) , 10.1111/TBJ.12062
Chandandeep S. Nagi, James E. O'Donnell, Mikhail Tismenetsky, Ira J. Bleiweiss, Shabnam M. Jaffer, Lobular neoplasia on core needle biopsy does not require excision. Cancer. ,vol. 112, pp. 2152- 2158 ,(2008) , 10.1002/CNCR.23415
Meghan R. Flanagan, Mara H. Rendi, Kristine E. Calhoun, Benjamin O. Anderson, Sara H. Javid, Pleomorphic Lobular Carcinoma In Situ: Radiologic–Pathologic Features and Clinical Management Annals of Surgical Oncology. ,vol. 22, pp. 4263- 4269 ,(2015) , 10.1245/S10434-015-4552-X
Chung-Che Chang, Ellen Bunyi-Teopengco, Camellia Eshoa, Christopher R. Chitambar, Bal Kampalath, Clinical, Histopathologic, and Biologic Features of Pleomorphic Lobular (Ductal-Lobular) Carcinoma In Situ of the Breast: A Report of 24 Cases Modern Pathology. ,vol. 15, pp. 1044- 1050 ,(2002) , 10.1097/01.MP.0000027624.08159.19
Yunn-Yi Chen, Eun-Sil Shelley Hwang, Ritu Roy, Sandy DeVries, Joseph Anderson, Chrystal Wa, Patrick L. Fitzgibbons, Timothy W. Jacobs, Gaetan MacGrogan, Hans Peterse, Anne Vincent-Salomon, Taku Tokuyasu, Stuart J. Schnitt, Frederic M. Waldman, Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. The American Journal of Surgical Pathology. ,vol. 33, pp. 1683- 1694 ,(2009) , 10.1097/PAS.0B013E3181B18A89
Diana Bell, George H. Perkins, Lavinia P. Middleton, Nour Sneige, Erinn Downs-Kelly, Clinical Implications of Margin Involvement by Pleomorphic Lobular Carcinoma In Situ Archives of Pathology & Laboratory Medicine. ,vol. 135, pp. 737- 743 ,(2011) , 10.1043/2010-0204-OA.1